Immediate Impact

3 by Nobel laureates 7 from Science/Nature 80 standout
Sub-graph 1 of 21

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
3 intermediate papers

Works of Leena Helle being referenced

Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
2011
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
2009

Author Peers

Author Last Decade Papers Cites
Leena Helle 451 247 44 152 11 513
C. Höß 339 285 34 163 14 563
Christopher Stokoe 468 249 27 185 16 520
Henry Taupin 403 205 26 110 7 471
Mette S. van Ramshorst 398 359 13 141 20 548
M. Pegram 438 193 24 178 12 551
Maeve Waldron-Lynch 412 240 16 89 21 541
Debbie Frye 391 368 24 42 13 546
Valerie Bée 289 142 17 137 13 459
Karen Afenjar 446 186 10 161 15 551
G. Raab 474 471 43 63 19 633

All Works

Loading papers...

Rankless by CCL
2026